Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 11, Issue 2, Pages 49-53Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/S1043-2760(99)00223-4
Keywords
-
Categories
Ask authors/readers for more resources
For two decades it has been assumed that inhibition of carnitine palmitoyl-transferase I (CPT-1) by malonyl-CoA represents the main regulatory mechanism Of liver ketogenesis. However, recent evidence indicates that CPT-I activity is also controlled by interactions between mitochondria and cytoskeletal components. This newly recognized mechanism emphasizes the emerging role of the cytoskeleton in the regulation of metabolic pathways.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available